Filing Details
- Accession Number:
- 0000905148-25-000826
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 17:11:13
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 17:11:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1731790 | Ying Du | C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Acquisiton | 2025-02-28 | 50,000 | $0.60 | 544,117 | No | 4 | M | Direct | |
| American Depositary Shares | Disposition | 2025-02-28 | 2,857 | $33.59 | 541,260 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2025-02-28 | 46,943 | $34.52 | 494,317 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2025-02-28 | 200 | $35.06 | 494,117 | No | 4 | S | Direct | |
| American Depositary Shares | Acquisiton | 2025-03-03 | 50,000 | $0.60 | 544,117 | No | 4 | M | Direct | |
| American Depositary Shares | Disposition | 2025-03-03 | 23,110 | $31.75 | 521,007 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2025-03-03 | 24,280 | $32.99 | 496,727 | No | 4 | S | Direct | |
| American Depositary Shares | Disposition | 2025-03-03 | 2,610 | $33.50 | 494,117 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| American Depositary Shares | Stock Options (Right to Buy) | Disposition | 2025-02-28 | 50,000 | $0.00 | 50,000 | $0.60 |
| American Depositary Shares | Stock Options (Right to Buy) | Disposition | 2025-03-03 | 50,000 | $0.00 | 50,000 | $0.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 539,165 | 2025-10-22 | No | 4 | M | Direct | |
| 489,165 | 2025-10-22 | No | 4 | M | Direct |
Footnotes
- Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024.
- Reflects a weighted average sale price of $33.594 per share, at prices ranging from $33.04 to $34.015 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $34.5201 per share, at prices ranging from $34.04 to $34.99 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $35.055 per share, at prices ranging from $35.05 to $35.06 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $31.7479 per share, at prices ranging from $31.31 to $32.29 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $32.9907 per share, at prices ranging from $32.34 to $33.33 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects a weighted average sale price of $33.499 per share, at prices ranging from $33.34 to $33.67 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The Stock Options fully vested as of October 22, 2020.
Billionaire Hedge Funds
